Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Market Growth 2022-2028

  • LP 4926336
  • 92 Pages
  • March 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs will have significant change from previous year. According to our (LP Information) latest study, the global ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs market, reaching US$ million by the year 2028. As for the Europe ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs players cover GlaxoSmithKline, Helsinn, Heron Therapeutics, and Merck, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

5-HT3 Inhibitors

NK1 Inhibitors

Other

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Highly Emetogenic Chemotherapy

Moderately Emetogenic Chemotherapy

Low Emetogenic Chemotherapy

Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

GlaxoSmithKline

Helsinn

Heron Therapeutics

Merck

Tesaro

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs by Country/Region, 2017, 2022 & 2028

2.2 ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Segment by Type

2.2.1 5-HT3 Inhibitors

2.2.2 NK1 Inhibitors

2.2.3 Other

2.3 ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Type

2.3.1 Global ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Type (2017-2022)

2.3.2 Global ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Revenue and Market Share by Type (2017-2022)

2.3.3 Global ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Sale Price by Type (2017-2022)

2.4 ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Segment by Application

2.4.1 Highly Emetogenic Chemotherapy

2.4.2 Moderately Emetogenic Chemotherapy

2.4.3 Low Emetogenic Chemotherapy

2.4.4 Other

2.5 ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Application

2.5.1 Global ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Sale Market Share by Application (2017-2022)

2.5.2 Global ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Revenue and Market Share by Application (2017-2022)

2.5.3 Global ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Sale Price by Application (2017-2022)

3 Global ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs by Company

3.1 Global ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Breakdown Data by Company

3.1.1 Global ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Annual Sales by Company (2020-2022)

3.1.2 Global ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Company (2020-2022)

3.2 Global ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Annual Revenue by Company (2020-2022)

3.2.1 Global ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Company (2020-2022)

3.2.2 Global ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share by Company (2020-2022)

3.3 Global ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Sale Price by Company

3.4 Key Manufacturers ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Product Location Distribution

3.4.2 Players ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs by Geographic Region

4.1 World Historic ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Market Size by Geographic Region (2017-2022)

4.1.1 Global ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Annual Sales by Geographic Region (2017-2022)

4.1.2 Global ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Annual Revenue by Geographic Region

4.2 World Historic ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Market Size by Country/Region (2017-2022)

4.2.1 Global ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Annual Sales by Country/Region (2017-2022)

4.2.2 Global ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Annual Revenue by Country/Region

4.3 Americas ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Sales Growth

4.4 APAC ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Sales Growth

4.5 Europe ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Sales Growth

4.6 Middle East & Africa ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Sales Growth

5 Americas

5.1 Americas ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Country

5.1.1 Americas ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Country (2017-2022)

5.1.2 Americas ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Country (2017-2022)

5.2 Americas ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Type

5.3 Americas ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Region

6.1.1 APAC ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Region (2017-2022)

6.1.2 APAC ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Region (2017-2022)

6.2 APAC ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Type

6.3 APAC ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs by Country

7.1.1 Europe ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Country (2017-2022)

7.1.2 Europe ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Country (2017-2022)

7.2 Europe ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Type

7.3 Europe ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs by Country

8.1.1 Middle East & Africa ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Country (2017-2022)

8.1.2 Middle East & Africa ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Country (2017-2022)

8.2 Middle East & Africa ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Type

8.3 Middle East & Africa ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs

10.3 Manufacturing Process Analysis of ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs

10.4 Industry Chain Structure of ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Distributors

11.3 ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Customer

12 World Forecast Review for ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs by Geographic Region

12.1 Global ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Market Size Forecast by Region

12.1.1 Global ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Forecast by Region (2023-2028)

12.1.2 Global ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Forecast by Type

12.7 Global ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Forecast by Application

13 Key Players Analysis

13.1 GlaxoSmithKline

13.1.1 GlaxoSmithKline Company Information

13.1.2 GlaxoSmithKline ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Product Offered

13.1.3 GlaxoSmithKline ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 GlaxoSmithKline Main Business Overview

13.1.5 GlaxoSmithKline Latest Developments

13.2 Helsinn

13.2.1 Helsinn Company Information

13.2.2 Helsinn ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Product Offered

13.2.3 Helsinn ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Helsinn Main Business Overview

13.2.5 Helsinn Latest Developments

13.3 Heron Therapeutics

13.3.1 Heron Therapeutics Company Information

13.3.2 Heron Therapeutics ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Product Offered

13.3.3 Heron Therapeutics ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Heron Therapeutics Main Business Overview

13.3.5 Heron Therapeutics Latest Developments

13.4 Merck

13.4.1 Merck Company Information

13.4.2 Merck ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Product Offered

13.4.3 Merck ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Merck Main Business Overview

13.4.5 Merck Latest Developments

13.5 Tesaro

13.5.1 Tesaro Company Information

13.5.2 Tesaro ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Product Offered

13.5.3 Tesaro ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Tesaro Main Business Overview

13.5.5 Tesaro Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of 5-HT3 Inhibitors

Table 4. Major Players of NK1 Inhibitors

Table 5. Major Players of Other

Table 6. Global ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Type (2017-2022) & (K Pcs)

Table 7. Global ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Type (2017-2022)

Table 8. Global ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Type (2017-2022) & ($ million)

Table 9. Global ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share by Type (2017-2022)

Table 10. Global ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Sale Price by Type (2017-2022) & (USD/Pcs)

Table 11. Global ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Application (2017-2022) & (K Pcs)

Table 12. Global ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Application (2017-2022)

Table 13. Global ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Application (2017-2022)

Table 14. Global ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share by Application (2017-2022)

Table 15. Global ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Sale Price by Application (2017-2022) & (USD/Pcs)

Table 16. Global ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Company (2020-2022) & (K Pcs)

Table 17. Global ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Company (2020-2022)

Table 18. Global ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Company (2020-2022) ($ Millions)

Table 19. Global ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share by Company (2020-2022)

Table 20. Global ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Sale Price by Company (2020-2022) & (USD/Pcs)

Table 21. Key Manufacturers ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Producing Area Distribution and Sales Area

Table 22. Players ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Products Offered

Table 23. ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 24. New Products and Potential Entrants

Table 25. Mergers & Acquisitions, Expansion

Table 26. Global ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Geographic Region (2017-2022) & (K Pcs)

Table 27. Global ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share Geographic Region (2017-2022)

Table 28. Global ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Geographic Region (2017-2022) & ($ millions)

Table 29. Global ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share by Geographic Region (2017-2022)

Table 30. Global ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Country/Region (2017-2022) & (K Pcs)

Table 31. Global ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Country/Region (2017-2022)

Table 32. Global ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Country/Region (2017-2022) & ($ millions)

Table 33. Global ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share by Country/Region (2017-2022)

Table 34. Americas ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Country (2017-2022) & (K Pcs)

Table 35. Americas ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Country (2017-2022)

Table 36. Americas ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 37. Americas ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share by Country (2017-2022)

Table 38. Americas ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Type (2017-2022) & (K Pcs)

Table 39. Americas ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Type (2017-2022)

Table 40. Americas ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Application (2017-2022) & (K Pcs)

Table 41. Americas ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Application (2017-2022)

Table 42. APAC ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Region (2017-2022) & (K Pcs)

Table 43. APAC ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Region (2017-2022)

Table 44. APAC ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Region (2017-2022) & ($ Millions)

Table 45. APAC ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share by Region (2017-2022)

Table 46. APAC ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Type (2017-2022) & (K Pcs)

Table 47. APAC ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Type (2017-2022)

Table 48. APAC ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Application (2017-2022) & (K Pcs)

Table 49. APAC ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Application (2017-2022)

Table 50. Europe ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Country (2017-2022) & (K Pcs)

Table 51. Europe ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Country (2017-2022)

Table 52. Europe ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 53. Europe ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share by Country (2017-2022)

Table 54. Europe ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Type (2017-2022) & (K Pcs)

Table 55. Europe ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Type (2017-2022)

Table 56. Europe ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Application (2017-2022) & (K Pcs)

Table 57. Europe ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Application (2017-2022)

Table 58. Middle East & Africa ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Country (2017-2022) & (K Pcs)

Table 59. Middle East & Africa ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Country (2017-2022)

Table 60. Middle East & Africa ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 61. Middle East & Africa ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share by Country (2017-2022)

Table 62. Middle East & Africa ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Type (2017-2022) & (K Pcs)

Table 63. Middle East & Africa ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Type (2017-2022)

Table 64. Middle East & Africa ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Application (2017-2022) & (K Pcs)

Table 65. Middle East & Africa ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Application (2017-2022)

Table 66. Key Market Drivers & Growth Opportunities of ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs

Table 67. Key Market Challenges & Risks of ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs

Table 68. Key Industry Trends of ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs

Table 69. ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Raw Material

Table 70. Key Suppliers of Raw Materials

Table 71. ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Distributors List

Table 72. ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Customer List

Table 73. Global ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Sales Forecast by Region (2023-2028) & (K Pcs)

Table 74. Global ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Forecast by Region

Table 75. Global ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Forecast by Region (2023-2028) & ($ millions)

Table 76. Global ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share Forecast by Region (2023-2028)

Table 77. Americas ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Sales Forecast by Country (2023-2028) & (K Pcs)

Table 78. Americas ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 79. APAC ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Sales Forecast by Region (2023-2028) & (K Pcs)

Table 80. APAC ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Forecast by Region (2023-2028) & ($ millions)

Table 81. Europe ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Sales Forecast by Country (2023-2028) & (K Pcs)

Table 82. Europe ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 83. Middle East & Africa ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Sales Forecast by Country (2023-2028) & (K Pcs)

Table 84. Middle East & Africa ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Global ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Sales Forecast by Type (2023-2028) & (K Pcs)

Table 86. Global ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share Forecast by Type (2023-2028)

Table 87. Global ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 88. Global ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share Forecast by Type (2023-2028)

Table 89. Global ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Sales Forecast by Application (2023-2028) & (K Pcs)

Table 90. Global ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share Forecast by Application (2023-2028)

Table 91. Global ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 92. Global ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share Forecast by Application (2023-2028)

Table 93. GlaxoSmithKline Basic Information, ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Manufacturing Base, Sales Area and Its Competitors

Table 94. GlaxoSmithKline ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Product Offered

Table 95. GlaxoSmithKline ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 96. GlaxoSmithKline Main Business

Table 97. GlaxoSmithKline Latest Developments

Table 98. Helsinn Basic Information, ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Manufacturing Base, Sales Area and Its Competitors

Table 99. Helsinn ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Product Offered

Table 100. Helsinn ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 101. Helsinn Main Business

Table 102. Helsinn Latest Developments

Table 103. Heron Therapeutics Basic Information, ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Manufacturing Base, Sales Area and Its Competitors

Table 104. Heron Therapeutics ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Product Offered

Table 105. Heron Therapeutics ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 106. Heron Therapeutics Main Business

Table 107. Heron Therapeutics Latest Developments

Table 108. Merck Basic Information, ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Manufacturing Base, Sales Area and Its Competitors

Table 109. Merck ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Product Offered

Table 110. Merck ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 111. Merck Main Business

Table 112. Merck Latest Developments

Table 113. Tesaro Basic Information, ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Manufacturing Base, Sales Area and Its Competitors

Table 114. Tesaro ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Product Offered

Table 115. Tesaro ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 116. Tesaro Main Business

Table 117. Tesaro Latest Developments

List of Figures

Figure 1. Picture of ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs

Figure 2. ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Sales Growth Rate 2017-2028 (K Pcs)

Figure 7. Global ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of 5-HT3 Inhibitors

Figure 10. Product Picture of NK1 Inhibitors

Figure 11. Product Picture of Other

Figure 12. Global ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Type in 2021

Figure 13. Global ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share by Type (2017-2022)

Figure 14. ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Consumed in Highly Emetogenic Chemotherapy

Figure 15. Global ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Market: Highly Emetogenic Chemotherapy (2017-2022) & (K Pcs)

Figure 16. ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Consumed in Moderately Emetogenic Chemotherapy

Figure 17. Global ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Market: Moderately Emetogenic Chemotherapy (2017-2022) & (K Pcs)

Figure 18. ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Consumed in Low Emetogenic Chemotherapy

Figure 19. Global ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Market: Low Emetogenic Chemotherapy (2017-2022) & (K Pcs)

Figure 20. ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Consumed in Other

Figure 21. Global ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Market: Other (2017-2022) & (K Pcs)

Figure 22. Global ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Application (2017-2022)

Figure 23. Global ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share by Application in 2021

Figure 24. ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market by Company in 2021 ($ Million)

Figure 25. Global ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share by Company in 2021

Figure 26. Global ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Geographic Region (2017-2022)

Figure 27. Global ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share by Geographic Region in 2021

Figure 28. Global ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Region (2017-2022)

Figure 29. Global ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share by Country/Region in 2021

Figure 30. Americas ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Sales 2017-2022 (K Pcs)

Figure 31. Americas ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Revenue 2017-2022 ($ Millions)

Figure 32. APAC ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Sales 2017-2022 (K Pcs)

Figure 33. APAC ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Revenue 2017-2022 ($ Millions)

Figure 34. Europe ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Sales 2017-2022 (K Pcs)

Figure 35. Europe ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Revenue 2017-2022 ($ Millions)

Figure 36. Middle East & Africa ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Sales 2017-2022 (K Pcs)

Figure 37. Middle East & Africa ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Revenue 2017-2022 ($ Millions)

Figure 38. Americas ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Country in 2021

Figure 39. Americas ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share by Country in 2021

Figure 40. United States ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 41. Canada ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 42. Mexico ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 43. Brazil ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 44. APAC ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Region in 2021

Figure 45. APAC ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share by Regions in 2021

Figure 46. China ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 47. Japan ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 48. South Korea ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 49. Southeast Asia ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 50. India ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 51. Australia ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 52. Europe ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Country in 2021

Figure 53. Europe ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share by Country in 2021

Figure 54. Germany ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 55. France ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 56. UK ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 57. Italy ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 58. Russia ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 59. Middle East & Africa ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Country in 2021

Figure 60. Middle East & Africa ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share by Country in 2021

Figure 61. Egypt ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 62. South Africa ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 63. Israel ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 64. Turkey ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 65. GCC Country ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 66. Manufacturing Cost Structure Analysis of ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs in 2021

Figure 67. Manufacturing Process Analysis of ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs

Figure 68. Industry Chain Structure of ChemOtherapy Induced Nausea and Vomiting (CINV) Drugs

Figure 69. Channels of Distribution

Figure 70. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390